CME Group (CME) Stock Forecast, Price & News

CME Group (NASDAQ:CME) Frequently Asked Questions

Is CME Group a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View analyst ratings for CME Group or view top-rated stocks.

When is CME Group's next earnings date?

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for CME Group.

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) issued its earnings results on Wednesday, April, 27th. The financial services provider reported $2.11 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.11. The financial services provider earned $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. CME Group had a net margin of 57.98% and a trailing twelve-month return on equity of 9.29%. The company's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.79 EPS.
View CME Group's earnings history.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group declared a quarterly dividend on Wednesday, May 4th. Shareholders of record on Friday, June 10th will be given a dividend of $1.00 per share on Monday, June 27th. This represents a $4.00 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date of this dividend is Thursday, June 9th.
View CME Group's dividend history.

Is CME Group a good dividend stock?

CME Group pays an annual dividend of $4.00 per share and currently has a dividend yield of 2.04%. CME Group has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of CME Group is 52.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME Group will have a dividend payout ratio of 47.90% next year. This indicates that CME Group will be able to sustain or increase its dividend.
View CME Group's dividend history.

What price target have analysts set for CME?

14 brokerages have issued 1 year price targets for CME Group's stock. Their forecasts range from $201.00 to $280.00. On average, they anticipate CME Group's share price to reach $252.85 in the next year. This suggests a possible upside of 29.0% from the stock's current price.
View analysts' price targets for CME Group or view top-rated stocks among Wall Street analysts.

Who are CME Group's key executives?

CME Group's management team includes the following people:

• Mr. Terrence A. Duffy, Chairman & CEO (Age 64, Pay $11.33M)
• Mr. John William Pietrowicz CPA, M.B.A., Chief Financial Officer (Age 58, Pay $1.51M)
• Ms. Julie Holzrichter, Sr. MD & COO (Age 53, Pay $1.31M) (LinkedIn Profile)
• Mr. Sunil Cutinho, Chief Information Officer (Age 50, Pay $1.24M) (LinkedIn Profile)
• Mr. Kevin D. Kometer, Advisor (Age 57, Pay $1.31M)
• Mr. Jack Tobin, MD & Chief Accounting Officer (Age 58)
• Mr. John C. Peschier, Managing Director of Investor Relations (Age 54)
• Ms. Kathleen M. Cronin, Sr. MD, Gen. Counsel & Corp. Sec. (Age 59) (LinkedIn Profile)
• Ms. Anita Liskey, Sr. Managing Director of Corp. Marketing & Communications (Age 57)
• Ms. Hilda Harris Piell, Sr. MD & Chief HR Officer (Age 54) (LinkedIn Profile)

What is Terry Duffy's approval rating as CME Group's CEO?

144 employees have rated CME Group CEO Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among CME Group's employees.

Who are some of CME Group's key competitors?

Some companies that are related to CME Group include Intercontinental Exchange (ICE), Moody's (MCO), MSCI (MSCI), Nasdaq (NDAQ), Interactive Brokers Group (IBKR), MarketAxess (MKTX), Arrow Financial (AROW) and California First Leasing (CFNB).
View all of CME's competitors.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

Who are CME Group's major shareholders?

CME Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.86%), BlackRock Inc. (6.75%), State Street Corp (4.67%), Edgewood Management LLC (2.60%), Bank of New York Mellon Corp (1.80%) and Parnassus Investments LLC (1.66%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends for CME Group.

Which major investors are selling CME Group stock?

CME stock was sold by a variety of institutional investors in the last quarter, including Edgewood Management LLC, Parnassus Investments LLC, Sarasin & Partners LLP, Healthcare of Ontario Pension Plan Trust Fund, Bank of New York Mellon Corp, Fiera Capital Corp, Caisse DE Depot ET Placement DU Quebec, and UBS Group AG. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, and Timothy S Bitsberger.
View insider buying and selling activity for CME Group or view top insider-selling stocks.

Which major investors are buying CME Group stock?

CME stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, TD Asset Management Inc., Lord Abbett & CO. LLC, Vanguard Group Inc., Ensign Peak Advisors Inc, Invesco Ltd., Primecap Management Co. CA, and Renaissance Technologies LLC. Company insiders that have bought CME Group stock in the last two years include Terrence A Duffy, and William R Shepard.
View insider buying and selling activity for CME Group or or view top insider-buying stocks.

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $196.03.

How much money does CME Group make?

CME Group has a market capitalization of $70.46 billion and generates $4.69 billion in revenue each year. The financial services provider earns $2.64 billion in net income (profit) each year or $7.659990 on an earnings per share basis.

How many employees does CME Group have?

CME Group employs 3,480 workers across the globe.

When was CME Group founded?

CME Group was founded in 1848.

What is CME Group's official website?

The official website for CME Group is www.cmegroup.com.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at (312) 930-1000, via email at [email protected], or via fax at 312-466-4410.